Your browser doesn't support javascript.
loading
Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography.
Sanders, Margreet F; van Doormaal, Pieter Jan; Beeftink, Martine M A; Bots, Michiel L; Fadl Elmula, Fadl Elmula M; Habets, Jesse; Hammer, Frank; Hoffmann, Pavel; Jacobs, Lotte; Mark, Patrick B; Persu, Alexandre; Renkin, Jean; Roditi, Giles; Spiering, Wilko; Staessen, Jan A; Taylor, Alison H; Verloop, Willemien L; Vink, Eva E; Vonken, Evert-Jan; Voskuil, Michiel; Leiner, Tim; Blankestijn, Peter J.
Afiliação
  • Sanders MF; Department of Nephrology and Hypertension, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands.
  • van Doormaal PJ; Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Beeftink MMA; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Bots ML; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Fadl Elmula FEM; Department of Internal Medicine and Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway.
  • Habets J; Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hammer F; Department of Radiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Hoffmann P; Section for Interventional Cardiology, Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway.
  • Jacobs L; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • Mark PB; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, UK.
  • Persu A; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
  • Renkin J; Cardiology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Roditi G; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
  • Spiering W; Cardiology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Staessen JA; Department of Radiology, Glasgow Royal Infirmary, Glasgow, UK.
  • Taylor AH; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Verloop WL; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • Vink EE; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, UK.
  • Vonken EJ; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Voskuil M; Department of Nephrology and Hypertension, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands.
  • Leiner T; Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Blankestijn PJ; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Eur Radiol ; 27(9): 3934-3941, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28271154
ABSTRACT

OBJECTIVES:

Relatively little is known about the incidence of long-term renal damage after renal denervation (RDN), a potential new treatment for hypertension. In this study the incidence of renal artery and parenchymal changes, assessed with contrast-enhanced magnetic resonance angiography (MRA) after RDN, is investigated.

METHODS:

This study is an initiative of ENCOReD, a collaboration of hypertension expert centres. Patients in whom an MRA was performed before and after RDN were included. Scans were evaluated by two independent, blinded radiologists. Primary outcome was the change in renal artery morphology and parenchyma.

RESULTS:

MRAs from 96 patients were analysed. Before RDN, 41 renal anomalies were observed, of which 29 mostly mild renal artery stenoses. After a median time of 366 days post RDN, MRA showed a new stenosis (25-49% lumen reduction) in two patients and progression of pre-existing lumen reduction in a single patient. No other renal changes were observed and renal function remained stable.

CONCLUSIONS:

We observed new or progressed renal artery stenosis in three out of 96 patients, after a median time of 12 months post RDN (3.1%). Procedural angiographies showed that ablations were applied near the observed stenosis in only one of the three patients. KEY POINTS • The incidence of vascular changes 12 months post RDN was 3.1%. • No renal vascular or parenchymal changes other than stenoses were observed. • Ablations were applied near the stenosis in only one of three patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artéria Renal / Obstrução da Artéria Renal / Simpatectomia Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Radiol Assunto da revista: RADIOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artéria Renal / Obstrução da Artéria Renal / Simpatectomia Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Radiol Assunto da revista: RADIOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda